John J Hollatz, Executive Vice President at NUCOR CORP (NASDAQ:NUE), conducted a significant sale of company common stock on June 3, 2026. According to SEC filings detailing the transactions, Mr. Hollatz disposed of approximately $2.7 million worth of shares.
The specific transaction involved the divestiture of 10,560 shares of Nucor's common stock. These sales were executed following the exercise of employee stock options. The disposal occurred at variable prices, ranging from $258.3301 to $258.5701 per share, resulting in a total sale value estimated at $2,729,291.
Details of Stock Acquisition and Divestment
Prior to executing the sales, Mr. Hollatz had acquired these 10,560 shares through the exercise of employee stock options. The acquisition was structured across two separate blocks. In the first block, he obtained 5,522 shares with an exercise price of $130.71 per share. For the second block, he secured 5,038 shares at a higher exercise cost of $133.03 per share.
The total value attributed to these acquired shares was approximately $1,391,985. The stock options utilized in this process were described in the filing as a 'right to buy.' For the initial set of shares, the exercise date was recorded as June 1, 2025, and carried an expiration date of May 31, 2032. The second block featured an exercise date of June 1, 2026, with a corresponding expiration date of May 31, 2033.
Following the recent sell-off, Mr. Hollatz's remaining direct holdings in Nucor common stock amount to 97,865.39 shares.
The reported insider activity must be viewed alongside Nucor’s more immediate corporate performance and market metrics. The company recently released robust first-quarter earnings for 2026, which significantly outperformed analyst consensus. Specifically, Nucor achieved earnings per share (EPS) of $3.23, surpassing the forecasted expectation of $2.82. Furthermore, revenue reached a substantial $9.5 billion, exceeding the anticipated figure of $8.88 billion.
This strong operational performance prompted BMO Capital to adjust its assessment of Nucor. The firm raised its price target for NUE from $235 to $250, while maintaining an Outperform rating on the shares. An analyst at BMO Capital, Katja Jancic, contributed commentary highlighting the company’s positive outlook, which reinforced the financial institution's favorable stance toward the stock.
These recent developments indicate a generally positive trajectory for Nucor. Investor interest has been pronounced following these announcements, as reflected by the stock's recent trading activity. Currently, NUE trades at $262.99, positioning it near its 52-week high of $261.46, which follows an impressive return of 114.7% over the last year.
Risks
- The market analysis suggests that Nucor’s stock may be overvalued relative to its Fair Value, as indicated by placement on the Most Overvalued list.
- The recent sale of shares by an EVP following the exercise of options introduces a short-term element of insider selling activity.
More from Insider Trading
Risks
- The market analysis suggests that Nucor’s stock may be overvalued relative to its Fair Value, as indicated by placement on the Most Overvalued list.
- The recent sale of shares by an EVP following the exercise of options introduces a short-term element of insider selling activity.